Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2024-08-20 00:00:00 ET · period of report 2024-08-16 · accession 0000950170-24-099269 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-08-20 | 2024-08-19 | BBIO | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale+OE | $24.69 | -4,155 | 86.9K | -5% | -$102.6K |
| DT | 2024-08-20 | 2024-08-16 | BBIO | STEPHENSON BRIAN C | CFO, Sec, Treas | F - Tax | $24.40 | -13.1K | 89.3K | -13% | -$319.1K |
| DT | 2024-08-20 | 2024-08-16 | BBIO | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | — | +25.8K | 102.4K | +34% | — |
| DMT | 2024-08-20 | 2024-08-16 | BBIO | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | $0.00 | -25.8K | 93.9K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-19 | S | D | 1,698 | $25.13 | 85,192 | D | — | — | (F6) Represents the weighted average sale price of the shares sold ranging from $24.91 to $25.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-08-16 | F | D | 13,077 | $24.40 | 89,347 | D | — | — | (F3) Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 25,797 shares of Common Stock underlying the Reporting Person's RSUs. |
| 3 | Common | Common Stock | 2024-08-16 | M | A | 25,797 | — | 102,424 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F2) Includes 155 shares of the Issuer's Common Stock acquired by the Reporting Person on August 15, 2024 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. |
| 4 | Common | Common Stock | 2024-08-19 | S | D | 2,457 | $24.39 | 86,890 | D | — | — | (F5) Represents the weighted average sale price of the shares sold ranging from $23.91 to $24.90 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 5 | Derivative | Restricted Stock Units | 2024-08-16 | M | D | 778 | $0.00 | 1,557 | D | — · — to — | 778 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F7) The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. |
| 6 | Derivative | Restricted Stock Units | 2024-08-16 | M | D | 17,368 | $0.00 | 173,684 | D | — · — to — | 17,368 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F9) The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. |
| 7 | Derivative | Restricted Stock Units | 2024-08-16 | M | D | 946 | $0.00 | 4,733 | D | — · — to — | 946 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F8) The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. |
| 8 | Derivative | Restricted Stock Units | 2024-08-16 | M | D | 6,705 | $0.00 | 93,869 | D | — · — to — | 6,705 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F10) The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. |